|Articles|November 7, 2019
HCP monitoring in downstream process samples
Author(s)PharmaFluidics
µPAC™ technology has been used for analysing HCP impurities originating from recombinant expression systems used in the production of mAb based biotherapeutics.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Voices from the Analytical Front Line: Tony Edge on Chromatography in 2026
2
Chromatographic Extraction and LC–Triple Quadrupole Mass Spectrometric Determination of Acrylamide in Powdered Infant Formulas
3
Velaris Announces Acquisition of Markes International
4
Best of the Week: Chromatography Trends, The Peptide Revolution
5